The Neb-90™ Large Volume Medication Nebulizer is indicated for the continuous aerosol administration of respiratory medication (inhalable solution) including, but not necessarily limited to, beta adrenergic bronchodilator (albuterol sulfate) and/or a wetting agent such as sodium chloride solution (saline) that is used for the treatment of respiratory and related diseases and conditions including, but not necessarily limited to asthma, COPD, bronchiolitis and cystic fibrosis. The Neb-90™ Large Volume Medication Nebulizer is for use in hospital Emergency Department, ICU or other similar settings for delivery of aerosolized medication to patients undergoing severe respiratory distress.

Device Description

The Nebulizer is a single patient/single use device which is filled with a fluid, typically respiratory medication and connected to a gas source via flexible tubing. The nebulizer works by Pavipng a cluid come into contact with the stream of gas. The gas shatters the liquid into small particles. These particles then impact a baffle that further reduces the size of the particles. The majority of the larger particles settle inside the nebulizer as a result of gravity and inertia, returning the mist to liquid to repeat the nebulization process. The smaller particles are then administered as the patient inhales. The treatment is completed when the majority of liquid has been nebulized.

AI/ML Overview

The provided text describes a 510(k) summary for the Neb-90™ Large Volume Medication Nebulizer but does not include any acceptance criteria or details of a study demonstrating the device meets such criteria.

The document states that the Neb-90™ is a single-patient/single-use device for the continuous aerosol administration of respiratory medication. It also mentions that "Specific issues, as mentioned in 'CDRH Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators; October 1, 1993' are addressed herewith," but the document does not elaborate on what these issues are or how they were addressed with data.

Therefore, based on the provided input, I cannot generate the requested table or answer the questions regarding acceptance criteria and study details. The 510(k) summary focuses on device description, predicate devices, general device characteristics, and the FDA's clearance letter, but it omits the specific performance data and acceptance criteria that would typically be found in a study report.

Summary

{0}------------------------------------------------

510(k) SUMMARY for

JUN 3 0 2008

Neb-90™ Large Volume Medication Nebulizer

1. SUBMITTER INFORMATION:

Medi/Nuclear Corporation, Inc. 4610 Littlejohn Street Baldwin Park, CA 91706-2267

Establishment
Registration Number:	2050098
Primary contact:	Jerry Schoen
	Chief Operating Officer
	Medi/Nuclear & Healthline Medical
Telephone Number:	(800) 321-5981 (corporate toll-free)
	(626) 960-9822 (Los Angeles local)
Fax:	(626) 960-8700 (corporate fax)
E-mail:	jschoen@medinuclear.com
Secondary contact:	Russell King
	Owner/Chairman, Medi/Nuclear & Healthline Medical
Telephone Number:	(800) 321-5981 (corporate toll-free)
	(626) 960-9822 (Los Angeles local)
Fax:	(626) 960-8700 (corporate fax)

Note: Medi/Nuclear Corporation, Inc. markets the products it manufacturers to the nuclear medicine industry under its own name. However, it also markets some of the same products to the respiratory therapy industry under the name of its affiliate company, Healthline Medical. Both companies share the same building, facilities, staff and management team at the above-listed address. The Neb-90 will be private-labeled for Healthline Medical upon receipt of clearance to market.

2. DEVICE NAME:

Classification Name:	Nebulizer (CAF), direct patient interface
Regulation:	21CFR868.5630
Proprietary Name:	Healthline Neb-90™ Large Volume Medication Nebulizer (LVN), Hereinafter referred to as "Neb-90"

3. PREDICATE DEVICE:

Medi/Nuclear Neb-3A Patient Nebulizer (K915075) Smiths Medical - DHD Health Flo-Mist [B&B Medical Technologies Inc. Hope Nebulizer (K980407)

{1}------------------------------------------------

DESCRIPTION OF DEVICE:

General Questions & Answers

Specific issues, as mentioned in "CDRH Reviewer Guidance for Nebulizers, Metered Dose Inhalers, Spacers and Actuators; October 1, 1993" are addressed herewith:

	Question	Yes	No
1	Is the device life-supporting or life-sustaining?		X
2	Is the device an implant (short-term or long-term)?		X
3	Is the device sterile?		X
4	Is the device for single use?	X
5	Is the device prescription use?	X
6	Is the device for home use or portable?		X
7	Does the device contain a drug or biological product as a component?		X
8	Is this device a kit? *		X
9	Is the device software-driven?		X
10	Is the device electrically operated?		X
11	Are there applicable standards for this device to which conformance has beendemonstrated in addition to those already mentioned (e.g., IEC, ANSF, ASTM,etc)?		X

*The Neb-90™ in of itself is not a kit; however it will be marketed as a component of a kit, ARK-1, LG-ARK-1, ARK-5, LG-ARK-5, AM-690A and AM-690P.

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three wing-like shapes, representing health, services, and people. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN 3 0 2008

Mr. Michael McPeck Director, Aerosol Medicine Medi/Nuclear Corporation, Incorporated 4610 Littlejohn Street Baldwin Park, California 91706

Re: K080657

Trade/Device Name: Neb-90TM Large Volume Medication Nebulizer Regulation Number: 21 CFR 868.5630 Regulation Name: Nebulizer Regulatory Class: II Product Code: CAF Dated: June 19, 2008 Received: June 23, 2008

Dear Mr. McPeck:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Mr. McPeck

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Clare

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Medi/Nuclear Corporation, Inc. 4610 Littlejohn Street Baldwin Park, CA 91706-2267

Indications for Use Statement

510(k) Number K080657

Neb-90™ Large Volume Medication Nebulizer Device Name:

Indications for Use:

The Neb-90™ Large Volume Medication Nebulizer is for use in hospital Emergency Department, ICU or other similar settings for delivery of aerosolized medication to patients undergoing severe respiratory distress.

Concurrence of CDRH, Office of Device Evaluation (ODE):

Prescription Use X Over-The-Counter Use

Prescription Use __

Min-Xh

(Division Sign-Off) (Division Sign-On)
Division of Anesthesiology, General Hospital
Division of Anesthesiology, General Devices Division of Amol, Dental Devices

-10(k) Number: K0840657

Page 2 of 39 Neb-90 Submission

Regulation Number and Section

§ 868.5630 Nebulizer.

(a)
Identification. A nebulizer is a device intended to spray liquids in aerosol form into gases that are delivered directly to the patient for breathing. Heated, ultrasonic, gas, venturi, and refillable nebulizers are included in this generic type of device.(b)
Classification. Class II (performance standards).